论文信息 - Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II Study - 字舞流文

Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II Study

D. Esseltine | S. Jagannath | A. Jakubowiak | S. Lonial | N. Munshi | P. Richardson | C. Mitsiades | N. Raje | T. Hideshima | I. Ghobrial | D. Vesole | R. Schlossman | R. Joyce | D. Avigan | R. Knight | A. Mazumder | D. Warren | D. Doss | K. Anderson | S. Hayes | S. Kaster | Carol Delaney | Marisa Lauria